The traditional gold standard of clinical trials with a randomized, placebo-controlled design involving hundreds of patients ...
Ethics committees and funding agencies often receive protocols that involve either too many or too few animals to answer the specific research question being investigated. It is evident that a greater ...
After Replimune’s advanced melanoma drug was rejected for a second time, CEO Sushil Patel slammed the FDA for failing to ...
Lyell Immunopharma, Inc. (LYEL) 25th Annual Needham Virtual Healthcare Conference April 14, 2026 11:00 AM EDTCompany ParticipantsLynn Seely - ...
A Tuesday news release from the town says the issue was discovered by the town’s third-party website developer, Black Dog ...
The frequency of DTH reactions increased by approximately 4x (290%) in the total open-label non-HLA-A*02 population, increasing from 5.2% of the patients experiencing a DTH reaction at baseline, prior ...
Dana-Farber Cancer Institute researchers will present more than 50 studies at the American Association for Cancer Research ...
Dana-Farber Cancer Institute researchers will present more than 50 studies at the American Association for Cancer Research ...
LB Pharmaceuticals Inc (LBRX) 25th Annual Needham Virtual Healthcare Conference April 16, 2026 11:45 AM EDTCompany ParticipantsHeather Turner - CEO ...
In an interview with Targeted Oncology, Naomi Haas, MD, discusses the evolving landscape of adjuvant and neoadjuvant immune ...
The risks and benefits of hormone replacement therapy use for menopausal symptoms in breast cancer survivors are examined in light of recent research.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results